Relief Therapeutics Holding AG
Relief Therapeutics Holding AG RLFTF Peers
See (RLFTF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RLFTF | $3.61 | -4.50% | 45.40M | -2.21 | -$1.63 | N/A |
| NONOF | $66.92 | +1.04% | 297.06B | 18.96 | $3.53 | +2.50% |
| CSLLY | $79.95 | +1.00% | 154.85B | 29.39 | $2.72 | +1.66% |
| CMXHF | $164.51 | +9.27% | 79.66B | 30.19 | $5.45 | +1.68% |
| ARGNF | $562.00 | N/A | 34.32B | 34.25 | $16.41 | N/A |
| UCBJY | $87.92 | -3.21% | 33.42B | 28.55 | $3.08 | +0.62% |
| UCBJF | $175.75 | N/A | 33.40B | 28.58 | $6.15 | +0.72% |
| ODTC | $22,005.00 | +29.44% | 24.14B | -0.08 | -$268,995.00 | N/A |
| GNMSF | $208.35 | N/A | 12.81B | 12.23 | $17.04 | N/A |
| WXXWY | $6.00 | -0.83% | 12.21B | 27.27 | $0.22 | N/A |
Stock Comparison
RLFTF vs NONOF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, NONOF has a market cap of 297.06B. Regarding current trading prices, RLFTF is priced at $3.61, while NONOF trades at $66.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas NONOF's P/E ratio is 18.96. In terms of profitability, RLFTF's ROE is -1.08%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, RLFTF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs CSLLY Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, CSLLY has a market cap of 154.85B. Regarding current trading prices, RLFTF is priced at $3.61, while CSLLY trades at $79.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas CSLLY's P/E ratio is 29.39. In terms of profitability, RLFTF's ROE is -1.08%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, RLFTF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs CMXHF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, CMXHF has a market cap of 79.66B. Regarding current trading prices, RLFTF is priced at $3.61, while CMXHF trades at $164.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas CMXHF's P/E ratio is 30.19. In terms of profitability, RLFTF's ROE is -1.08%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, RLFTF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs ARGNF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, ARGNF has a market cap of 34.32B. Regarding current trading prices, RLFTF is priced at $3.61, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, RLFTF's ROE is -1.08%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, RLFTF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs UCBJY Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, UCBJY has a market cap of 33.42B. Regarding current trading prices, RLFTF is priced at $3.61, while UCBJY trades at $87.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas UCBJY's P/E ratio is 28.55. In terms of profitability, RLFTF's ROE is -1.08%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, RLFTF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs UCBJF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, UCBJF has a market cap of 33.40B. Regarding current trading prices, RLFTF is priced at $3.61, while UCBJF trades at $175.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas UCBJF's P/E ratio is 28.58. In terms of profitability, RLFTF's ROE is -1.08%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, RLFTF is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs ODTC Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, ODTC has a market cap of 24.14B. Regarding current trading prices, RLFTF is priced at $3.61, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas ODTC's P/E ratio is -0.08. In terms of profitability, RLFTF's ROE is -1.08%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, RLFTF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs GNMSF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, GNMSF has a market cap of 12.81B. Regarding current trading prices, RLFTF is priced at $3.61, while GNMSF trades at $208.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas GNMSF's P/E ratio is 12.23. In terms of profitability, RLFTF's ROE is -1.08%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, RLFTF is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs WXXWY Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, WXXWY has a market cap of 12.21B. Regarding current trading prices, RLFTF is priced at $3.61, while WXXWY trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas WXXWY's P/E ratio is 27.27. In terms of profitability, RLFTF's ROE is -1.08%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, RLFTF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs WXIBF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, WXIBF has a market cap of 12.19B. Regarding current trading prices, RLFTF is priced at $3.61, while WXIBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas WXIBF's P/E ratio is 27.27. In terms of profitability, RLFTF's ROE is -1.08%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, RLFTF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs IVBXF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, IVBXF has a market cap of 12.19B. Regarding current trading prices, RLFTF is priced at $3.61, while IVBXF trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas IVBXF's P/E ratio is -739.00. In terms of profitability, RLFTF's ROE is -1.08%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, RLFTF is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs SBMFF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, SBMFF has a market cap of 8.86B. Regarding current trading prices, RLFTF is priced at $3.61, while SBMFF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas SBMFF's P/E ratio is 49.50. In terms of profitability, RLFTF's ROE is -1.08%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, RLFTF is less volatile compared to SBMFF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs SBHMY Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, SBHMY has a market cap of 8.48B. Regarding current trading prices, RLFTF is priced at $3.61, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, RLFTF's ROE is -1.08%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, RLFTF is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs TRSBF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, TRSBF has a market cap of 6.46B. Regarding current trading prices, RLFTF is priced at $3.61, while TRSBF trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas TRSBF's P/E ratio is 22.83. In terms of profitability, RLFTF's ROE is -1.08%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, RLFTF is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs TLPPF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, TLPPF has a market cap of 5.59B. Regarding current trading prices, RLFTF is priced at $3.61, while TLPPF trades at $16.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas TLPPF's P/E ratio is 183.80. In terms of profitability, RLFTF's ROE is -1.08%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, RLFTF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs ABCZF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, ABCZF has a market cap of 5.12B. Regarding current trading prices, RLFTF is priced at $3.61, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, RLFTF's ROE is -1.08%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, RLFTF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs INCPF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, INCPF has a market cap of 4.88B. Regarding current trading prices, RLFTF is priced at $3.61, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas INCPF's P/E ratio is -108.67. In terms of profitability, RLFTF's ROE is -1.08%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, RLFTF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs AKBLF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, AKBLF has a market cap of 4.75B. Regarding current trading prices, RLFTF is priced at $3.61, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas AKBLF's P/E ratio is 33.89. In terms of profitability, RLFTF's ROE is -1.08%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, RLFTF is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs LABFF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, LABFF has a market cap of 4.63B. Regarding current trading prices, RLFTF is priced at $3.61, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas LABFF's P/E ratio is 28.95. In terms of profitability, RLFTF's ROE is -1.08%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, RLFTF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs ZLDPF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, ZLDPF has a market cap of 4.41B. Regarding current trading prices, RLFTF is priced at $3.61, while ZLDPF trades at $62.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas ZLDPF's P/E ratio is -24.08. In terms of profitability, RLFTF's ROE is -1.08%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, RLFTF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs SHJBF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, SHJBF has a market cap of 3.40B. Regarding current trading prices, RLFTF is priced at $3.61, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, RLFTF's ROE is -1.08%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, RLFTF is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs CAMRF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, CAMRF has a market cap of 3.28B. Regarding current trading prices, RLFTF is priced at $3.61, while CAMRF trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas CAMRF's P/E ratio is 58.95. In terms of profitability, RLFTF's ROE is -1.08%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, RLFTF is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs REGMF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, REGMF has a market cap of 3.24B. Regarding current trading prices, RLFTF is priced at $3.61, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas REGMF's P/E ratio is -13.32. In terms of profitability, RLFTF's ROE is -1.08%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, RLFTF is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs GNNSF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, GNNSF has a market cap of 2.91B. Regarding current trading prices, RLFTF is priced at $3.61, while GNNSF trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas GNNSF's P/E ratio is -16.94. In terms of profitability, RLFTF's ROE is -1.08%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, RLFTF is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs TKBIF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, TKBIF has a market cap of 2.79B. Regarding current trading prices, RLFTF is priced at $3.61, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, RLFTF's ROE is -1.08%, compared to TKBIF's ROE of N/A. Regarding short-term risk, RLFTF is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs MPSYF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, MPSYF has a market cap of 2.76B. Regarding current trading prices, RLFTF is priced at $3.61, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, RLFTF's ROE is -1.08%, compared to MPSYF's ROE of +7.43%. Regarding short-term risk, RLFTF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs ASPHF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, ASPHF has a market cap of 2.24B. Regarding current trading prices, RLFTF is priced at $3.61, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, RLFTF's ROE is -1.08%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, RLFTF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs BVNKF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, BVNKF has a market cap of 2.09B. Regarding current trading prices, RLFTF is priced at $3.61, while BVNKF trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas BVNKF's P/E ratio is 10.59. In terms of profitability, RLFTF's ROE is -1.08%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, RLFTF is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs BVNRY Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, BVNRY has a market cap of 1.98B. Regarding current trading prices, RLFTF is priced at $3.61, while BVNRY trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas BVNRY's P/E ratio is 10.12. In terms of profitability, RLFTF's ROE is -1.08%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, RLFTF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs BTTAY Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, BTTAY has a market cap of 1.92B. Regarding current trading prices, RLFTF is priced at $3.61, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas BTTAY's P/E ratio is -69.23. In terms of profitability, RLFTF's ROE is -1.08%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, RLFTF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs GENSF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, GENSF has a market cap of 1.83B. Regarding current trading prices, RLFTF is priced at $3.61, while GENSF trades at $27.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas GENSF's P/E ratio is -348.31. In terms of profitability, RLFTF's ROE is -1.08%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, RLFTF is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs MEOBF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, MEOBF has a market cap of 1.82B. Regarding current trading prices, RLFTF is priced at $3.61, while MEOBF trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas MEOBF's P/E ratio is -15.89. In terms of profitability, RLFTF's ROE is -1.08%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, RLFTF is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs GLPGF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, GLPGF has a market cap of 1.81B. Regarding current trading prices, RLFTF is priced at $3.61, while GLPGF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas GLPGF's P/E ratio is -8.96. In terms of profitability, RLFTF's ROE is -1.08%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, RLFTF is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs PPTDF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, PPTDF has a market cap of 1.75B. Regarding current trading prices, RLFTF is priced at $3.61, while PPTDF trades at $13.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas PPTDF's P/E ratio is 17.13. In terms of profitability, RLFTF's ROE is -1.08%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, RLFTF is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs PHMMF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, PHMMF has a market cap of 1.69B. Regarding current trading prices, RLFTF is priced at $3.61, while PHMMF trades at $96.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas PHMMF's P/E ratio is 76.35. In terms of profitability, RLFTF's ROE is -1.08%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, RLFTF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs BRCTF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, BRCTF has a market cap of 1.66B. Regarding current trading prices, RLFTF is priced at $3.61, while BRCTF trades at $18.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas BRCTF's P/E ratio is 17.85. In terms of profitability, RLFTF's ROE is -1.08%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, RLFTF is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs BIESF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, BIESF has a market cap of 1.63B. Regarding current trading prices, RLFTF is priced at $3.61, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas BIESF's P/E ratio is -45.07. In terms of profitability, RLFTF's ROE is -1.08%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, RLFTF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs ONTTF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, ONTTF has a market cap of 1.54B. Regarding current trading prices, RLFTF is priced at $3.61, while ONTTF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas ONTTF's P/E ratio is -7.62. In terms of profitability, RLFTF's ROE is -1.08%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, RLFTF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs CSBTF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, CSBTF has a market cap of 1.15B. Regarding current trading prices, RLFTF is priced at $3.61, while CSBTF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas CSBTF's P/E ratio is -250.00. In terms of profitability, RLFTF's ROE is -1.08%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, RLFTF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs NURPF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, NURPF has a market cap of 1.02B. Regarding current trading prices, RLFTF is priced at $3.61, while NURPF trades at $8.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas NURPF's P/E ratio is 11.67. In terms of profitability, RLFTF's ROE is -1.08%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, RLFTF is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs SNBIF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, SNBIF has a market cap of 1.00B. Regarding current trading prices, RLFTF is priced at $3.61, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, RLFTF's ROE is -1.08%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, RLFTF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs ASCLF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, ASCLF has a market cap of 865.80M. Regarding current trading prices, RLFTF is priced at $3.61, while ASCLF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas ASCLF's P/E ratio is -22.33. In terms of profitability, RLFTF's ROE is -1.08%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, RLFTF is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs CSPHF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, CSPHF has a market cap of 702.96M. Regarding current trading prices, RLFTF is priced at $3.61, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, RLFTF's ROE is -1.08%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, RLFTF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs PHGUF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, PHGUF has a market cap of 680.31M. Regarding current trading prices, RLFTF is priced at $3.61, while PHGUF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, RLFTF's ROE is -1.08%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, RLFTF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs BPMUF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, BPMUF has a market cap of 582.74M. Regarding current trading prices, RLFTF is priced at $3.61, while BPMUF trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas BPMUF's P/E ratio is 6.81. In terms of profitability, RLFTF's ROE is -1.08%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, RLFTF is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs INRLF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, INRLF has a market cap of 543.23M. Regarding current trading prices, RLFTF is priced at $3.61, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas INRLF's P/E ratio is -5.16. In terms of profitability, RLFTF's ROE is -1.08%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, RLFTF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs SOLTF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, SOLTF has a market cap of 534.16M. Regarding current trading prices, RLFTF is priced at $3.61, while SOLTF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas SOLTF's P/E ratio is -32.83. In terms of profitability, RLFTF's ROE is -1.08%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, RLFTF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs BXPHF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, BXPHF has a market cap of 517.79M. Regarding current trading prices, RLFTF is priced at $3.61, while BXPHF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas BXPHF's P/E ratio is -26.50. In terms of profitability, RLFTF's ROE is -1.08%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, RLFTF is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs IVEVF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, IVEVF has a market cap of 505.87M. Regarding current trading prices, RLFTF is priced at $3.61, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, RLFTF's ROE is -1.08%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, RLFTF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs CLTEF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, CLTEF has a market cap of 504.72M. Regarding current trading prices, RLFTF is priced at $3.61, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, RLFTF's ROE is -1.08%, compared to CLTEF's ROE of -0.61%. Regarding short-term risk, RLFTF is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs CKDXF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, CKDXF has a market cap of 470.61M. Regarding current trading prices, RLFTF is priced at $3.61, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, RLFTF's ROE is -1.08%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, RLFTF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs AAVXF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, AAVXF has a market cap of 457.38M. Regarding current trading prices, RLFTF is priced at $3.61, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas AAVXF's P/E ratio is -2.30. In terms of profitability, RLFTF's ROE is -1.08%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, RLFTF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs VBIZF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, VBIZF has a market cap of 456.09M. Regarding current trading prices, RLFTF is priced at $3.61, while VBIZF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas VBIZF's P/E ratio is 21.89. In terms of profitability, RLFTF's ROE is -1.08%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, RLFTF is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs TBGNF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, TBGNF has a market cap of 433.72M. Regarding current trading prices, RLFTF is priced at $3.61, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, RLFTF's ROE is -1.08%, compared to TBGNF's ROE of N/A. Regarding short-term risk, RLFTF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs CYDY Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, CYDY has a market cap of 413.48M. Regarding current trading prices, RLFTF is priced at $3.61, while CYDY trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas CYDY's P/E ratio is -16.78. In terms of profitability, RLFTF's ROE is -1.08%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, RLFTF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs HBMHF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, HBMHF has a market cap of 407.69M. Regarding current trading prices, RLFTF is priced at $3.61, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, RLFTF's ROE is -1.08%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, RLFTF is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs PTCHF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, PTCHF has a market cap of 403.52M. Regarding current trading prices, RLFTF is priced at $3.61, while PTCHF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas PTCHF's P/E ratio is 8.00. In terms of profitability, RLFTF's ROE is -1.08%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, RLFTF is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs NWBO Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, NWBO has a market cap of 397.75M. Regarding current trading prices, RLFTF is priced at $3.61, while NWBO trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas NWBO's P/E ratio is -4.60. In terms of profitability, RLFTF's ROE is -1.08%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, RLFTF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs IDRSF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, IDRSF has a market cap of 377.58M. Regarding current trading prices, RLFTF is priced at $3.61, while IDRSF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas IDRSF's P/E ratio is -1.04. In terms of profitability, RLFTF's ROE is -1.08%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, RLFTF is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs CLVLF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, CLVLF has a market cap of 348.36M. Regarding current trading prices, RLFTF is priced at $3.61, while CLVLF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas CLVLF's P/E ratio is 14.18. In terms of profitability, RLFTF's ROE is -1.08%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, RLFTF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs CLVLY Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, CLVLY has a market cap of 346.86M. Regarding current trading prices, RLFTF is priced at $3.61, while CLVLY trades at $6.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas CLVLY's P/E ratio is 14.12. In terms of profitability, RLFTF's ROE is -1.08%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, RLFTF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs BOVNF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, BOVNF has a market cap of 309.28M. Regarding current trading prices, RLFTF is priced at $3.61, while BOVNF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, RLFTF's ROE is -1.08%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, RLFTF is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs PRRUF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, PRRUF has a market cap of 306.68M. Regarding current trading prices, RLFTF is priced at $3.61, while PRRUF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas PRRUF's P/E ratio is -10.50. In terms of profitability, RLFTF's ROE is -1.08%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, RLFTF is less volatile compared to PRRUF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs PBBIF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, PBBIF has a market cap of 286.93M. Regarding current trading prices, RLFTF is priced at $3.61, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, RLFTF's ROE is -1.08%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, RLFTF is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs NGENF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, NGENF has a market cap of 280.43M. Regarding current trading prices, RLFTF is priced at $3.61, while NGENF trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas NGENF's P/E ratio is -14.44. In terms of profitability, RLFTF's ROE is -1.08%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, RLFTF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs ORYZF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, ORYZF has a market cap of 234.86M. Regarding current trading prices, RLFTF is priced at $3.61, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, RLFTF's ROE is -1.08%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, RLFTF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs NWPHF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, NWPHF has a market cap of 231.22M. Regarding current trading prices, RLFTF is priced at $3.61, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas NWPHF's P/E ratio is N/A. In terms of profitability, RLFTF's ROE is -1.08%, compared to NWPHF's ROE of N/A. Regarding short-term risk, RLFTF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs MDCLF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, MDCLF has a market cap of 230.69M. Regarding current trading prices, RLFTF is priced at $3.61, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, RLFTF's ROE is -1.08%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, RLFTF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs HLOSF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, HLOSF has a market cap of 228.29M. Regarding current trading prices, RLFTF is priced at $3.61, while HLOSF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas HLOSF's P/E ratio is -7.26. In terms of profitability, RLFTF's ROE is -1.08%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, RLFTF is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs SPHDF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, SPHDF has a market cap of 225.73M. Regarding current trading prices, RLFTF is priced at $3.61, while SPHDF trades at $17.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas SPHDF's P/E ratio is -3.97. In terms of profitability, RLFTF's ROE is -1.08%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, RLFTF is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs RAONF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, RAONF has a market cap of 211.95M. Regarding current trading prices, RLFTF is priced at $3.61, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas RAONF's P/E ratio is -20.33. In terms of profitability, RLFTF's ROE is -1.08%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, RLFTF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs FPHAF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, FPHAF has a market cap of 209.54M. Regarding current trading prices, RLFTF is priced at $3.61, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, RLFTF's ROE is -1.08%, compared to FPHAF's ROE of N/A. Regarding short-term risk, RLFTF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs VSBC Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, VSBC has a market cap of 207.03M. Regarding current trading prices, RLFTF is priced at $3.61, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas VSBC's P/E ratio is N/A. In terms of profitability, RLFTF's ROE is -1.08%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, RLFTF is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs FGHQF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, FGHQF has a market cap of 205.61M. Regarding current trading prices, RLFTF is priced at $3.61, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, RLFTF's ROE is -1.08%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, RLFTF is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs HNSBF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, HNSBF has a market cap of 203.44M. Regarding current trading prices, RLFTF is priced at $3.61, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, RLFTF's ROE is -1.08%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, RLFTF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs BSEM Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, BSEM has a market cap of 189.85M. Regarding current trading prices, RLFTF is priced at $3.61, while BSEM trades at $11.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas BSEM's P/E ratio is -20.39. In terms of profitability, RLFTF's ROE is -1.08%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, RLFTF is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs GNFTF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, GNFTF has a market cap of 176.25M. Regarding current trading prices, RLFTF is priced at $3.61, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, RLFTF's ROE is -1.08%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, RLFTF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs SCNLF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, SCNLF has a market cap of 176.05M. Regarding current trading prices, RLFTF is priced at $3.61, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, RLFTF's ROE is -1.08%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, RLFTF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs OPORF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, OPORF has a market cap of 164.88M. Regarding current trading prices, RLFTF is priced at $3.61, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas OPORF's P/E ratio is 12.00. In terms of profitability, RLFTF's ROE is -1.08%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, RLFTF is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs MLLCF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, MLLCF has a market cap of 155.61M. Regarding current trading prices, RLFTF is priced at $3.61, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas MLLCF's P/E ratio is -2.08. In terms of profitability, RLFTF's ROE is -1.08%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, RLFTF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs AVCTF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, AVCTF has a market cap of 153.80M. Regarding current trading prices, RLFTF is priced at $3.61, while AVCTF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas AVCTF's P/E ratio is -3.34. In terms of profitability, RLFTF's ROE is -1.08%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, RLFTF is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs RECEF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, RECEF has a market cap of 149.84M. Regarding current trading prices, RLFTF is priced at $3.61, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas RECEF's P/E ratio is -10.00. In terms of profitability, RLFTF's ROE is -1.08%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, RLFTF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs SLNCF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, SLNCF has a market cap of 137.44M. Regarding current trading prices, RLFTF is priced at $3.61, while SLNCF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas SLNCF's P/E ratio is -1.90. In terms of profitability, RLFTF's ROE is -1.08%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, RLFTF is less volatile compared to SLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs BRIBF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, BRIBF has a market cap of 134.10M. Regarding current trading prices, RLFTF is priced at $3.61, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, RLFTF's ROE is -1.08%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, RLFTF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs IPHYF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, IPHYF has a market cap of 133.63M. Regarding current trading prices, RLFTF is priced at $3.61, while IPHYF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas IPHYF's P/E ratio is -2.10. In terms of profitability, RLFTF's ROE is -1.08%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, RLFTF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs AAPGV Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, AAPGV has a market cap of 127.31M. Regarding current trading prices, RLFTF is priced at $3.61, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas AAPGV's P/E ratio is N/A. In terms of profitability, RLFTF's ROE is -1.08%, compared to AAPGV's ROE of N/A. Regarding short-term risk, RLFTF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs PRNAF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, PRNAF has a market cap of 126.87M. Regarding current trading prices, RLFTF is priced at $3.61, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, RLFTF's ROE is -1.08%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, RLFTF is more volatile compared to PRNAF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs AMGXF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, AMGXF has a market cap of 121.79M. Regarding current trading prices, RLFTF is priced at $3.61, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, RLFTF's ROE is -1.08%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, RLFTF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs PSTTF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, PSTTF has a market cap of 117.53M. Regarding current trading prices, RLFTF is priced at $3.61, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, RLFTF's ROE is -1.08%, compared to PSTTF's ROE of N/A. Regarding short-term risk, RLFTF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs EPRXF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, EPRXF has a market cap of 108.29M. Regarding current trading prices, RLFTF is priced at $3.61, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, RLFTF's ROE is -1.08%, compared to EPRXF's ROE of -1.99%. Regarding short-term risk, RLFTF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs ADOIF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, ADOIF has a market cap of 103.66M. Regarding current trading prices, RLFTF is priced at $3.61, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, RLFTF's ROE is -1.08%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, RLFTF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs PBIGF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, PBIGF has a market cap of 100.04M. Regarding current trading prices, RLFTF is priced at $3.61, while PBIGF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas PBIGF's P/E ratio is -8.56. In terms of profitability, RLFTF's ROE is -1.08%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, RLFTF is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs ADOCY Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, ADOCY has a market cap of 98.20M. Regarding current trading prices, RLFTF is priced at $3.61, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, RLFTF's ROE is -1.08%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, RLFTF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs MSCLF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, MSCLF has a market cap of 97.85M. Regarding current trading prices, RLFTF is priced at $3.61, while MSCLF trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas MSCLF's P/E ratio is 3.28. In terms of profitability, RLFTF's ROE is -1.08%, compared to MSCLF's ROE of -0.74%. Regarding short-term risk, RLFTF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs TRGNF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, TRGNF has a market cap of 92.35M. Regarding current trading prices, RLFTF is priced at $3.61, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas TRGNF's P/E ratio is -2.12. In terms of profitability, RLFTF's ROE is -1.08%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, RLFTF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs CMVLF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, CMVLF has a market cap of 90.12M. Regarding current trading prices, RLFTF is priced at $3.61, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas CMVLF's P/E ratio is -3.05. In terms of profitability, RLFTF's ROE is -1.08%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, RLFTF is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs IUGNF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, IUGNF has a market cap of 88.86M. Regarding current trading prices, RLFTF is priced at $3.61, while IUGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas IUGNF's P/E ratio is -1.19. In terms of profitability, RLFTF's ROE is -1.08%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, RLFTF is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs MCURF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, MCURF has a market cap of 86.53M. Regarding current trading prices, RLFTF is priced at $3.61, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas MCURF's P/E ratio is -16.90. In terms of profitability, RLFTF's ROE is -1.08%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, RLFTF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for RLFTF.
RLFTF vs ACHFF Comparison
RLFTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RLFTF stands at 45.40M. In comparison, ACHFF has a market cap of 83.70M. Regarding current trading prices, RLFTF is priced at $3.61, while ACHFF trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RLFTF currently has a P/E ratio of -2.21, whereas ACHFF's P/E ratio is -31.75. In terms of profitability, RLFTF's ROE is -1.08%, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, RLFTF is more volatile compared to ACHFF. This indicates potentially higher risk in terms of short-term price fluctuations for RLFTF.